11/18/2026 | Press release | Distributed by Public on 11/18/2026 15:32
OPERATING AND FINANCIAL REVIEW AND PROSPECTS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the sections of this annual report entitled "Information on the Company", and our consolidated financial statements and related notes thereto, included elsewhere in this annual report. In addition to historical financial information, the following discussion contains forward-looking statements that reflect our current plans, expectations, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this annual report, particularly in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements."
We have prepared our consolidated financial statements in accordance with U.S. GAAP. Our fiscal year ends on December 31 and references to fiscal years 2023, 2024, and 2025 are to the fiscal years ended December 31, 2023, 2024 and 2025, respectively. In accordance with Instruction 6 to Item 5 of Form 20-F, we are omitting from this annual report a discussion of our results of operations for fiscal year 2023. For a discussion of our results of operations for the fiscal year ended December 31, 2024 compared with the fiscal year ended December 31, 2023, see "Item 5. Operating and Financial Review and Prospects-A. Operating Results" in our Annual Report on Form 20-F for the fiscal year ended December 31, 2024, as filed with the SEC on April 29, 2025.
Overview
Our principal business is to own, develop, operate, manage, and support relaxation salons through franchising, through direct ownership of such salons, or through selling salons to investors and managing such salon operations on behalf of the investors, throughout Japan. We seek to be the leading provider of relaxation and bodywork services in the markets we serve and to become the most recognized brand in our industry through the steady and focused expansion of relaxation salons in key markets throughout Japan and potentially abroad.
We have suspended, for the time being, the opening of new salons and the development of additional franchises. We have also suspended, for the time being, growth through acquisitions, and our current strategy gives the highest priority to improving the profitability of our existing salons and growing revenue in our Digital Preventative Healthcare business. Under this strategy,
we evaluate the profitability of each salon on an ongoing basis, seek to improve the performance of underperforming salons, and close or transfer salons that do not meet our profitability thresholds.
As of December 31, 2025, we and our franchisees operated 292 salons, of which 148 were operated as Company-owned salons, 70 were operated by our franchisees, and 74 were investor-owned salons which the Company operated on their behalf. We consider both Company-owned salons and investor-owned salons which are managed by us as "directly-operated salons".
Key Financial Definitions
Revenue. Revenue consists of the following items: revenue from directly-operated salons, franchise revenue, and other revenues.
Cost of Revenue. The total cost of delivering services to customers consists of the following items: cost of goods sold, subcontract expenses, cost of franchise royalty and affiliation revenue, salon operating cost, salaries for therapists, legal and welfare expenses, provision for paid annual leave, travelling expenses, salon rent, depreciation and amortization, gain/loss from asset retirement obligation, interest expenses for asset retirement obligation, business consignment expenses, and others.
Selling, General and Administrative Expenses. Selling, general and administrative expenses, or SG&A, includes the costs to sell and deliver services and the costs to manage the company as follows: directors' compensations, salaries and allowances, bonuses, legal welfare expenses, provision for paid annual leave, recruiting expenses, travel expenses, advertising expenses, rent, taxes and duties, commission fees, compensations, depreciation and amortization, provision for doubtful accounts, and others.
Impairment Loss on Long-lived Assets. Long-lived assets include property and equipment, right-of-use lease assets, internal use software, and definite-lived intangible assets. The Company reviews the carrying value of long-lived assets for impairment whenever events or circumstances occur that indicate that the carrying value of the assets may not be recoverable. If the assets are not deemed to be recoverable, an impairment is recorded if the fair value of the asset grouping is less than the carrying value.
Non-U.S. GAAP Measures
Adjusted EBITDA. We define Adjusted EBITDA as net income (loss), adjusted to exclude: (i) dividend and interest income, (ii) interest expense, (iii) gain from bargain purchases, (iv) income tax expense, (v) depreciation and amortization, (vi) losses on sales of directly-owned salons to franchisees, (vii) gains (losses) on disposal of property and equipment, and other intangible assets (viii) impairment loss on long-lived assets and (ix) stock-based compensation expense. Management considers Adjusted EBITDA to be a measurement of performance which provides useful information to both management and investors.
We use Adjusted EBITDA to enhance our understanding of our operating performance, which represents our views concerning our performance in the ordinary, ongoing and customary course of our operations. We historically have found it helpful, and believe that investors have found it helpful, to consider an operating measure that excludes certain expenses relating to transactions not reflective of our core operations. Stock-based compensation expense represents non-cash charges related to equity awards granted by us. Our management believes the measurement of these amounts can vary considerably from period to period and depend substantially on factors that are not direct consequences of the performance of our Company. Therefore, our management believes that excluding these expenses facilitates comparisons of our operational results and financial performances in different periods, as well as comparisons against similarly determined non-GAAP financial measures of comparable companies.
The information about our operating performance provided by this financial measure is used by our management for a variety of purposes. We regularly communicate Adjusted EBITDA results to our board of directors, and we discuss with the board our interpretation of such results. We also compare our Adjusted EBITDA performance against internal targets as a key factor in evaluating our periodic operating performance at each salon level, segment level, and consolidated level, largely because we believe that this measure is indicative of how the fundamental business is performing and is being managed.
Adjusted EBITDA Margin. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA for a period by total revenue for the same period. We believe this measure is useful to investors because it presents Adjusted EBITDA relative to revenue and facilitates comparisons of that relationship across periods. Management uses Adjusted EBITDA margin to assess changes in performance relative to revenue.
Adjusted EBITDA and Adjusted EBITDA margin are supplemental non-U.S. GAAP financial measures and should not be considered in isolation or as substitutes for net income (loss), net income (loss) margin, cash flows from operating activities or other measures prepared in accordance with U.S. GAAP. These measures exclude items that affect our reported results, some of which may recur, and do not represent cash available for discretionary expenditures. Other companies may calculate similarly titled measures differently, limiting their usefulness for comparisons with our measures.
Key Performance Indicators
In assessing the performance of our relaxation business, we consider several key performance indicators used by management. We receive monthly performance reports from our system and our relaxation salons which include key performance indicators per salon including sales, number of customers, number of newly-acquired customers, number of repeat customers, sales per customer, and operation ratio. We believe these indicators provide us with useful data with which to measure our performance and to measure the performance of our own and our franchisees' relaxation salons.
These key indicators include:
The following table sets forth the above key performance indicators for the periods presented:
|
Number |
Number |
Total |
|||||||||||||||||||||||
|
of |
of Salons |
Customers |
Sales Per |
Repeat |
Operation |
||||||||||||||||||||
|
Salons |
with Data |
Served |
Customer |
Ratio |
Ratio |
||||||||||||||||||||
|
January 2023 |
312 |
266 |
77,657 |
JPY |
6,624 |
77.9 |
% |
48.3 |
% |
||||||||||||||||
|
February 2023 |
312 |
266 |
71,707 |
JPY |
6,612 |
78.5 |
% |
47.3 |
% |
||||||||||||||||
|
March 2023 |
311 |
273 |
78,063 |
JPY |
6,680 |
77.4 |
% |
45.8 |
% |
||||||||||||||||
|
April 2023 |
313 |
284 |
83,130 |
JPY |
6,669 |
77.0 |
% |
47.2 |
% |
||||||||||||||||
|
May 2023 |
314 |
284 |
86,895 |
JPY |
6,660 |
75.7 |
% |
47.5 |
% |
||||||||||||||||
|
June 2023 |
314 |
287 |
81,280 |
JPY |
6,801 |
76.0 |
% |
46.7 |
% |
||||||||||||||||
|
July 2023 |
315 |
290 |
88,240 |
JPY |
6,985 |
76.0 |
% |
48.1 |
% |
||||||||||||||||
|
August 2023 |
316 |
291 |
87,224 |
JPY |
6,946 |
74.6 |
% |
48.0 |
% |
||||||||||||||||
|
September 2023 |
315 |
290 |
84,393 |
JPY |
6,991 |
76.7 |
% |
47.0 |
% |
||||||||||||||||
|
October 2023 |
315 |
291 |
82,249 |
JPY |
6,891 |
77.4 |
% |
45.4 |
% |
||||||||||||||||
|
November 2023 |
313 |
289 |
75,290 |
JPY |
7,045 |
77.5 |
% |
43.9 |
% |
||||||||||||||||
|
December 2023 |
314 |
290 |
83,124 |
JPY |
7,271 |
77.7 |
% |
46.7 |
% |
||||||||||||||||
|
January 2024 |
311 |
287 |
74,533 |
JPY |
7,147 |
76.8 |
% |
44.7 |
% |
||||||||||||||||
|
February 2024 |
311 |
287 |
71,376 |
JPY |
7,099 |
77.6 |
% |
44.9 |
% |
||||||||||||||||
|
March 2024 |
312 |
288 |
77,854 |
JPY |
7,190 |
77.9 |
% |
45.7 |
% |
||||||||||||||||
|
April 2024 |
308 |
285 |
74,621 |
JPY |
7,143 |
75.9 |
% |
43.5 |
% |
||||||||||||||||
|
May 2024 |
307 |
284 |
80,512 |
JPY |
6,964 |
74.8 |
% |
44.9 |
% |
||||||||||||||||
|
June 2024 |
308 |
285 |
82,656 |
JPY |
7,061 |
75.6 |
% |
47.4 |
% |
||||||||||||||||
|
July 2024 |
309 |
286 |
81,580 |
JPY |
7,060 |
75.0 |
% |
46.6 |
% |
||||||||||||||||
|
August 2024 |
307 |
283 |
83,770 |
JPY |
7,144 |
75.1 |
% |
47.3 |
% |
||||||||||||||||
|
September 2024 |
308 |
284 |
82,401 |
JPY |
7,158 |
75.8 |
% |
48.0 |
% |
||||||||||||||||
|
October 2024 |
307 |
282 |
79,571 |
JPY |
6,923 |
76.6 |
% |
45.5 |
% |
||||||||||||||||
|
November 2024 |
308 |
283 |
75,760 |
JPY |
7,055 |
77.5 |
% |
44.6 |
% |
||||||||||||||||
|
December 2024 |
308 |
283 |
80,764 |
JPY |
7,384 |
77.6 |
% |
45.9 |
% |
||||||||||||||||
|
January 2025 |
308 |
284 |
75,451 |
JPY |
7,145 |
76.4 |
% |
44.8 |
% |
||||||||||||||||
|
February 2025 |
308 |
283 |
69,781 |
JPY |
7,107 |
77.0 |
% |
45.5 |
% |
||||||||||||||||
|
March 2025 |
307 |
283 |
77,315 |
JPY |
7,208 |
77.8 |
% |
45.6 |
% |
||||||||||||||||
|
April 2025 |
304 |
281 |
75,391 |
JPY |
7,196 |
77.6 |
% |
45.4 |
% |
||||||||||||||||
|
May 2025 |
303 |
280 |
80,631 |
JPY |
7,100 |
76.3 |
% |
46.1 |
% |
||||||||||||||||
|
June 2025 |
304 |
281 |
77,715 |
JPY |
7,266 |
77.3 |
% |
46.3 |
% |
||||||||||||||||
|
July 2025 |
302 |
279 |
76,544 |
JPY |
7,389 |
77.0 |
% |
44.8 |
% |
||||||||||||||||
|
August 2025 |
299 |
275 |
82,780 |
JPY |
7,530 |
76.5 |
% |
48.4 |
% |
||||||||||||||||
|
September 2025 |
299 |
274 |
72,236 |
JPY |
7,498 |
76.9 |
% |
44.9 |
% |
||||||||||||||||
|
October 2025 |
295 |
273 |
69,669 |
JPY |
7,445 |
77.8 |
% |
43.3 |
% |
||||||||||||||||
|
November 2025 |
293 |
273 |
67,800 |
JPY |
7,621 |
79.4 |
% |
43.9 |
% |
||||||||||||||||
|
December 2025 |
292 |
272 |
70,499 |
JPY |
7,926 |
77.8 |
% |
44.1 |
% |
||||||||||||||||
The following table sets forth sales of store operating rights for the periods presented.
|
Number of |
Gross Contractual |
||||||||
|
Year ended December 31, 2023 |
38 |
JPY |
1,710,500 |
||||||
|
Year ended December 31, 2024 |
60 |
JPY |
2,563,705 |
||||||
|
Year ended December 31, 2025 |
43 |
JPY |
1,742,064 |
||||||
Our Number of Salons was 292 as of December 31, 2025, compared to 308 as of December 31, 2024. The decrease reflects the closure of 19 salons, partly offset by the opening of three salons, as we closed salons that did not meet our profitability thresholds under our restructuring plan.
The number of Salons with Data was 272 as of December 31, 2025, compared to 283 as of December 31, 2024.
Total Customers Served was 895,812 for the year ended December 31, 2025, compared to 945,395 in the year ended December 31, 2024. We believe this decrease was primarily due to a decline in the number of new customers, which we attribute to increased consumer price levels in Japan, and to the decrease in the number of salons we operated.
Sales per Customer were JPY7,364 (US$47) in the year ended December 31, 2025, an increase from JPY7,111 (US$45) in the year ended December 31, 2024. We believe the increase is primarily attributable to our improved ability to recommend courses and treatment plans that match customer needs.
Our Repeat Ratio was 77.3% in the year ended December 31, 2025, an increase from 76.3% in the year ended December 31, 2024. We believe this increase was primarily due to the campaigns we conducted, including sales of discounted prepaid tickets, which increased the frequency of visits by our repeat customers.
Our Operation Ratio was 45.3% in the year ended December 31, 2025, a slight decrease from 45.7% in the year ended December 31, 2024. We believe this decrease was partly due to the allocation of certain operational staff from our salon business to promotional activities related to the issuance of World ID, which we began in September 2025 in collaboration with Tools for Humanity. We also believe the decrease reflects the decline in the number of new customers described above.
We sold the operating rights of 43 salon locations in the year ended December 31, 2025, as compared to 60 locations in the year ended December 31, 2024 and 38 locations in the year ended December 31, 2023. Revenue from the sale of directly-owned salons was JPY1,365,914 thousand (US$8,711 thousand) in the year ended December 31, 2025, as compared to JPY2,328,005 thousand (US$14,847 thousand) in the year ended December 31, 2024. We believe the decrease is primarily attributable to the smaller number of salons sold, reflecting our focus on improving the profitability of our existing salons.
Factors Impacting our Operating Results
We expect that our results of operations will be affected by a number of factors and will primarily depend on the global economy, general market conditions, customer preference, and the competitive environment.
Our revenues, operating results and financial performance are impacted by a multitude of factors, including, but not limited to:
Business Environment. According to the 2022 Yano Report, which is the most recent report on this topic published by Yano, the relaxation market continues to see industry consolidation and notable category entrants from athletic and personal training services, and body stretching. We believe that market share will be further transferred to the category leaders in the industry, as smaller, private operators sell their businesses for retirement and/or market competition reasons, which industry trends, as we believe, may benefit us if realized.
Cost of Services. The cost of service of relaxation business has been increasing. In our relaxation business, a substantial majority of our personnel are paid wages at or close to the statutory minimum wage. For the past decade, such minimum wage has been continuously increasing throughout Japan. In 2012, the minimum wage in Tokyo was JPY850 (US$5.42), but had risen to JPY1,072 (US$6.84) as of December 31, 2022, according to the Ministry of Health, Labor and Welfare. The trend continued in 2023 and in 2024. The minimum wage in Tokyo increased annually by 3.8% to JPY1,113 (US$7.10) as of December 31, 2023, by 4.5% to JPY1,163 (US$7.42) as of December 31, 2024, and by 5.4% to JPY1,226 (US$7.82) as of December 31, 2025. To mitigate the effect of rising wages and the related social insurance premiums, we have been actively converting therapists from employment contracts to independent contractor agreements under which their compensation is linked to the sales they generate. As a result, the number of contractor therapists increased during 2025, and the statutory social insurance and labor insurance premiums for our relaxation salon business decreased by JPY4,862 thousand in the year ended December 31, 2025 compared to the year ended December 31, 2024.
In addition, we are facing inflationary trends in general prices, including utility costs, due to factors such as geo-political developments and the recovery of the Japanese economy. We have updated our service prices in May 2023 as part of a renewal of our primary service lines in order to deal with such increased costs, as well as to adjust to the long-term trend of minimum wage increases. We may also consider further updates to our service prices to reflect such increases in our costs in the future.
Update of Business Model. Since the fourth quarter of 2021, we have sought to become more asset-light by selling our owned salons to third-party investors and continuing to operate these sold salons on behalf of the investors. We believe this model will maximize the return on capital investment in our relaxation salon segment and allow us to accelerate salon openings by reinvesting the proceeds from the sales of salons, improve operational efficiency by focusing on salon operations, and generate additional income from the salons that were sold to investors and are under our management. In 2025, we sold 43 salons, while we sold 60 salons in 2024.
Specific Health Guidance Program. In our Digital Preventative Healthcare Segment, we have been continuously involved in the Specific Health Guidance Program, promoted by the Ministry of Health, Labor and Welfare of Japan, which utilizes our upgraded Lav® application. We also provide similar services to employees at large corporations who are below the age of forty and are not eligible for the Specific Health Guidance Program. The total number of active subscription orders from corporate insurance associations, counting each association once even where it has contracted for both programs, was 102 as of December 31, 2025, compared with 97 as of December 31, 2024 and 74 as of December 31, 2023. The total number of users who participated in our Specific Health Guidance Program or the program for younger generations was 3,582 in the year ended December 31, 2025, compared with 3,129 in the year ended December 31, 2024 and 2,803 in the year ended December 31, 2023.
Business Restructuring. In response to our operating losses and liquidity constraints, we began implementing a comprehensive restructuring plan during the year ended December 31, 2025. The plan includes closing or transferring salons that do not meet our profitability thresholds, consolidating overlapping corporate functions across our group companies, and reducing selling, general and administrative expenses. Actions taken under the plan during the year ended December 31, 2025 included closing 19 salons, transferring 43 salons to investor-owners and continuing to convert therapists from employment contracts to commission-based independent contractor agreements. The plan is still being implemented, and the effects of individual actions cannot be separated from the other factors affecting our results of operations, so we have not quantified the effect of the plan as a single amount; its effects are reflected in the individual line items discussed in this section. We expect the plan to continue to affect our results of operations in future periods. See "Item 4. Information on the Company-Business Restructuring."
Proof of Human Verification Services. Since June 2025, we have performed "Orb" biometric verifications at our salon locations, initially under an outsourcing agreement with a Japanese advertising agency that acts as the primary contractor for Tools for Humanity in Japan, All of the verifications performed during the year ended December 31, 2025 were performed under that outsourcing arrangement. In December 2025, we entered into a Master Services Partnership Operator Agreement directly with Tools for Humanity and the World Foundation, and services under that agreement commenced in February 2026. As of December 31, 2025, Orb devices were installed at 139 of our locations, and the cumulative number of verifications performed at our locations was 20,440. Revenue from these services for the year ended December 31, 2025 was JPY32,619 thousand. Revenue from these arrangements is included within other revenues of our Digital Preventative Healthcare segment. We expect this revenue on per-verification basis to be non-recurring. In addition, since August 2026 we have operated under a hosting model under which we receive a fixed fee for each device installed and no longer receive fees based on the number of individuals verified, as described in "Item 4. Information on the Company-Subsequent Events-Change in Operating Model for Proof of Human Verification Services." Accordingly, comparisons of our results of operations between periods that include amounts attributable to this arrangement may not be indicative of our underlying operating performance.
Payment Schedule for Taxes and Social Insurance Premiums. As of December 31, 2025, we had national and local taxes and social insurance premiums that were past due in the aggregate amount of JPY250,154 thousand, for which we have agreed revised payment schedules with the relevant authorities, principally relating to interim consumption tax payments and withheld income tax. We are making payments in accordance with those schedules.
Cost of Financing. Our cost of financing increased during the year ended December 31, 2025 and has continued to increase thereafter. Our deemed loan from Kufu Company Holdings Inc. bears interest at 10.0% per annum, compared to an interest rate of 1.875% per annum on our short-term bank loans and a weighted average interest rate of 2.96% per annum on our long-term borrowings as of December 31, 2025.
Comparison of the Results for the Year Ended December 31, 2025 and December 31, 2024
|
(in thousands, except change % data and Adjusted EBITDA margin) |
Year ended December 31, |
Change (2025 vs 2024) |
||||||||||||||||||||||
|
Consolidated Statement of Operations: |
2025($) |
2025(¥) |
2024(¥) |
$ |
¥ |
% |
||||||||||||||||||
|
Revenues: |
||||||||||||||||||||||||
|
Relaxation Salon |
44,972 |
¥ |
7,051,584 |
¥ |
7,446,200 |
$ |
(2,517 |
) |
¥ |
(394,616 |
) |
(5.3 |
)% |
|||||||||||
|
Luxury Beauty |
3,455 |
541,767 |
699,301 |
(1,005 |
) |
¥ |
(157,534 |
) |
(22.5 |
)% |
||||||||||||||
|
Digital Preventative Healthcare |
1,073 |
168,270 |
153,633 |
93 |
¥ |
14,637 |
9.5 |
% |
||||||||||||||||
|
Total revenue |
49,500 |
7,761,621 |
8,299,134 |
(3,428 |
) |
¥ |
(537,513 |
) |
(6.5 |
)% |
||||||||||||||
|
Cost of revenues and operating expenses: |
||||||||||||||||||||||||
|
Cost of revenues |
38,445 |
6,028,244 |
6,052,849 |
(157 |
) |
¥ |
(24,605 |
) |
(0.4 |
)% |
||||||||||||||
|
Selling, general and administrative expenses |
16,417 |
2,574,145 |
2,241,515 |
2,121 |
¥ |
332,630 |
14.8 |
% |
||||||||||||||||
|
Impairment loss on long-lived assets and goodwill |
16,269 |
2,550,953 |
22,872 |
16,123 |
¥ |
2,528,081 |
- |
% |
||||||||||||||||
|
Total cost of revenues and operating expenses |
71,131 |
11,153,342 |
8,317,236 |
18,087 |
¥ |
2,836,106 |
34.1 |
% |
||||||||||||||||
|
Operating income (loss) |
(21,631 |
) |
¥ |
(3,391,721 |
) |
¥ |
(18,102 |
) |
$ |
(21,515 |
) |
¥ |
(3,373,619 |
) |
- |
% |
||||||||
|
Other income (expenses): |
||||||||||||||||||||||||
|
Dividend income |
0 |
2 |
2 |
- |
- |
- |
% |
|||||||||||||||||
|
Interest income |
1 |
110 |
8 |
1 |
¥ |
102 |
- |
% |
||||||||||||||||
|
Interest expense |
(422 |
) |
(66,185 |
) |
(49,745 |
) |
(105 |
) |
¥ |
(16,440 |
) |
- |
% |
|||||||||||
|
Gain from sales of salons |
992 |
155,525 |
40,631 |
733 |
114,894 |
282.8 |
% |
|||||||||||||||||
|
Other, net |
(231 |
) |
(36,194 |
) |
74,919 |
(709 |
) |
¥ |
(111,113 |
) |
- |
% |
||||||||||||
|
Total other income |
340 |
53,258 |
65,815 |
(80 |
) |
¥ |
(12,557 |
) |
(19.1 |
)% |
||||||||||||||
|
Income tax (benefit) expense |
1,940 |
304,118 |
(90,478 |
) |
2,517 |
¥ |
394,596 |
- |
% |
|||||||||||||||
|
Net income (loss) |
(23,231 |
) |
(3,642,581 |
) |
138,191 |
(24,112 |
) |
¥ |
(3,780,772 |
) |
- |
% |
||||||||||||
|
Adjusted EBITDA(1) |
(1,215 |
) |
¥ |
(190,484 |
) |
¥ |
417,467 |
$ |
(3,877 |
) |
¥ |
(607,951 |
) |
- |
% |
|||||||||
|
Adjusted EBITDA margin(2) |
(2.5 |
)% |
(2.5 |
)% |
5.0 |
% |
(7.5)pt. |
|||||||||||||||||
|
Reconciliation of non-GAAP measures: |
Year ended December 31, |
|||||||||||
|
(in thousands, except Adjusted EBITDA margin) |
2025($) |
2025(¥) |
2024(¥) |
|||||||||
|
Net income (loss) |
$ |
(23,231 |
) |
¥ |
(3,642,581 |
) |
¥ |
138,191 |
||||
|
Dividend income and interest income |
(1 |
) |
(112 |
) |
(10 |
) |
||||||
|
Interest expense |
422 |
66,185 |
49,745 |
|||||||||
|
Income tax expense (benefit) |
1,940 |
304,118 |
(90,478 |
) |
||||||||
|
Depreciation and amortization |
3,397 |
532,657 |
290,038 |
|||||||||
|
(Gains) losses on disposal of property and equipment, net, other |
$ |
(11 |
) |
(1,704 |
) |
7,109 |
||||||
|
Impairment loss on long-lived assets and goodwill |
16,269 |
2,550,953 |
22,872 |
|||||||||
|
Adjusted EBITDA |
(1,215 |
) |
¥ |
(190,484 |
) |
¥ |
417,467 |
|||||
|
Net income (loss) margin |
(46.9 |
)% |
(46.9 |
)% |
1.7 |
% |
||||||
|
Adjusted EBITDA margin |
(2.5 |
)% |
(2.5 |
)% |
5.0 |
% |
||||||
Revenues
Total revenues decreased by JPY537,513 thousand, or 6.5%, to JPY7,761,621 thousand in the year ended December 31, 2025 from JPY8,299,134 thousand in the year ended December 31, 2024. Revenue from our Relaxation Salon segment decreased by JPY394,616 thousand, or 5.3%. The decrease principally reflected lower revenue from the sale of directly-owned salons, which was JPY1,365,914 thousand in 2025 compared to JPY2,218,605 thousand in 2024, a decrease of JPY852,691 thousand, and lower franchise revenue, which decreased by JPY158,636 thousand. These decreases were partially offset by an increase of JPY616,711 thousand in revenue from our directly-operated salons, from JPY4,435,512 thousand to JPY5,052,223 thousand. Revenue from our Luxury Beauty segment decreased by JPY157,534 thousand, or 22.5%. Revenue from our Digital Preventative Healthcare segment increased by JPY14,637 thousand, or 9.5%. The decrease in revenue from our Luxury Beauty segment principally reflected the absence in 2025 of revenue from the sale of directly-owned salons, which was JPY109,400 thousand in the year ended December 31, 2024, together with a decrease in revenue from directly-operated salons and franchise fees from JPY589,901 thousand to JPY541,767 thousand (which include franchise fees of JPY550 thousand and JPY600 thousand, respectively). The increase in revenue from our Digital Preventative Healthcare segment principally reflected revenue of JPY32,619 thousand from our Proof of Human verification services.
Cost of revenues and operating expenses
Cost of revenues remained substantially unchanged at JPY6,028,244 thousand in the year ended December 31, 2025, compared to JPY6,052,849 thousand in the year ended December 31, 2024, despite the decrease in revenue, principally reflecting personnel costs at our directly-operated salons. Within cost of revenues, the cost of revenue from directly-operated salons increased by JPY173,903 thousand, the cost of franchise revenue decreased by JPY119,962 thousand, reflecting the decrease in franchise revenue, and the cost of other revenues decreased by JPY78,546 thousand, principally because sales of MOTHER Bracelet® and Gateway devices, which carry product costs, declined substantially, while the increase in other revenues was attributable to our Proof of Human verification services, which do not involve comparable product costs.
Selling, general and administrative expenses increased by JPY332,630 thousand, or 14.8%, to JPY2,574,145 thousand in the year ended December 31, 2025 from JPY2,241,515 thousand in the year ended December 31, 2024. The increase principally reflected higher depreciation and amortization, which increased by JPY257,548 thousand from JPY176,413 thousand in the year ended December 31, 2024 to JPY433,961 thousand in the year ended December 31, 2025. The inclusion for a full year in 2025, compared with three months in 2024, of the rehabilitation business that MEDIROM Rehab Solutions Inc. acquired on October 1, 2024 increased personnel and advertising expenses, but that increase was more than offset at the consolidated level by decreases elsewhere: our advertising expenses decreased from JPY155,362 thousand to JPY147,747 thousand and the payroll expenses included in selling, general and administrative expenses decreased from JPY718,456 thousand to JPY677,694 thousand. The remaining increase of JPY75,082 thousand was attributable to other components of selling, general and administrative expenses.
Impairment loss on long-lived assets and goodwill was JPY2,550,953 thousand in the year ended December 31, 2025, compared to JPY22,872 thousand in the year ended December 31, 2024. The impairment loss for 2025 comprised JPY1,903,458 thousand in the Relaxation Salon segment (including goodwill impairment of JPY179,385 thousand), JPY392,079 thousand in the Luxury Beauty segment (including goodwill impairment of JPY167,241 thousand), JPY96,656 thousand in the Digital Preventative Healthcare segment and JPY158,760 thousand in corporate and eliminations. See Note 4 and Note 16 to our consolidated financial statements included elsewhere in this annual report.
Operating loss
As a result of the foregoing, we recorded an operating loss of JPY3,391,721 thousand in the year ended December 31, 2025, compared to an operating loss of JPY18,102 thousand in the year ended December 31, 2024.
Other income (expenses)
Total other income decreased by JPY12,557 thousand, or 19.1%, to JPY53,258 thousand in the year ended December 31, 2025 from JPY65,815 thousand in the year ended December 31, 2024. Gain from sales of salons increased to JPY155,525 thousand from JPY40,631 thousand, and subsidies increased to JPY94,565 thousand from JPY13,855 thousand, while we recognized a loss on investment securities of JPY86,918 thousand and a loss on extinguishment of debt of JPY27,998 thousand in 2025. Interest expense increased by JPY16,440 thousand to JPY66,185 thousand, reflecting higher levels of borrowings and higher interest rates.
Income tax expense
We recorded income tax expense of JPY304,118 thousand in the year ended December 31, 2025, compared to an income tax benefit of JPY90,478 thousand in the year ended December 31, 2024, principally reflecting valuation allowances recorded against deferred tax assets. Changes in valuation allowances increased income tax expense by JPY1,392,896 thousand, and our effective income tax rate was (9.1)% in the year ended December 31, 2025, compared to the Japanese statutory tax rate of 34.6%.
Net loss
As a result of the foregoing, we recorded a net loss of JPY3,642,581 thousand in the year ended December 31, 2025, compared to net income of JPY138,191 thousand in the year ended December 31, 2024. Net loss attributable to shareholders of the Company was JPY3,634,280 thousand, and basic and diluted net loss per share was JPY459.92.
Comparison of the Results for the Year Ended December 31, 2024 and December 31, 2023
For a discussion of our results of operations for the fiscal year ended December 31, 2024 compared with the fiscal year ended December 31, 2023, see "Item 5. Operating and Financial Review and Prospects-A. Operating Results" in our annual report on Form 20-F for the fiscal year ended December 31, 2024, filed with the SEC on April 29, 2025.
Liquidity is a measure of our ability to meet potential cash requirements. As of December 31, 2025, we had cash and cash equivalents of JPY91,979 thousand (US$587 thousand), compared to JPY329,399 thousand as of December 31, 2024. We have generally funded our operations with cash flow from operations and sales of relaxation salons, and, when needed, with borrowings
from Japanese financial institutions and other debt or equity financings. Our principal uses for liquidity have been to fund development of new salons, acquisitions of salons or relaxation businesses from franchisees or third parties, our daily operations, and general working capital purposes. We have suspended new salon openings for the time being, and we plan to continue to sell salon operating rights to investors to fund our operations and debt service. See "Item 4. Information on the Company-Our Growth Strategy."
Going Concern
As of December 31, 2025, we had cash and cash equivalents of JPY91,979 thousand (US$587 thousand), a working capital deficit of JPY3,244,164 thousand, an accumulated deficit of JPY3,405,240 thousand and a shareholders' deficit of JPY2,623,771 thousand. For the year ended December 31, 2025, we incurred a net loss of JPY3,642,581 thousand and had negative cash flows from operating activities of JPY1,155,007 thousand. As of December 31, 2025, our total interest-bearing debt was JPY2,401,507 thousand, of which JPY1,601,548 thousand matures within twelve months of that date. In addition, as of December 31, 2025, we had taxes and social insurance premiums that were past due in the aggregate amount of JPY250,154 thousand, for which we have agreed revised payment schedules with the relevant Japanese tax and social insurance authorities.
We do not expect that our cash and cash equivalents as of December 31, 2025, together with cash expected to be generated from operations, will be sufficient to fund our operating expenses, capital expenditure requirements and debt service obligations for the twelve months following the issuance date of the audit opinion for the financial statements included elsewhere in this annual report. These conditions raise substantial doubt about our ability to continue as a going concern.
Management's plans to alleviate the conditions that raise substantial doubt include (i) restructuring our operations, including closing or transferring salons that do not meet our profitability thresholds, consolidating overlapping corporate functions and reducing selling, general and administrative expenses, (ii) continuing to sell salon operating rights to investors, (iii) refinancing and extending the maturities of our existing indebtedness, including the refinancing of our First Unsecured Convertible-Type Corporate Bonds with Share Options on December 31, 2025, the refinancing of our Fourth Unsecured Convertible-Type Corporate Bonds with Share Options into a loan on July 14, 2026 and the refinancing of our Second Unsecured Convertible-Type Corporate Bonds with Share Options into a loan on August 25, 2026, (iv) evaluating the disposition of non-core businesses and assets, and (v) seeking additional debt or equity financing. As of the date of this annual report, we have not entered into any definitive agreement with respect to, and our board of directors has not approved, any disposition of non-core businesses or assets.
With respect to clause (ii) above, the cash that our sales of salon operating rights generate is substantially less than the contractual value of those sales, because a significant portion of the consideration is settled other than in cash. For the year ended December 31, 2025, the total contractual value of the 43 salons sold was JPY1,742,064 thousand, whereas proceeds from the sale of salons reflected in our consolidated statements of cash flows were JPY540,140 thousand, with the balance settled through receivables or by offset against amounts payable on contemporaneous repurchases from the same purchaser. Over the same period we repurchased 47 salons for a total repurchase amount of JPY2,301,371 thousand, which exceeded the total contractual value of the salons sold during the year, and cash used for acquisitions of store operating rights, which includes salons repurchased from purchasers, was JPY491,184 thousand. As a result, the net cash generated by this element of our plans in 2025 was substantially smaller than the contractual value of the salons we sold, and the cash that it generates in future periods will depend on the mix of cash and non-cash settlement and on the extent of any repurchases. See Note 1 to our consolidated financial statements for the number of salons sold and repurchased and the related amounts.
Our ability to issue equity securities or obtain debt financing on acceptable terms, or at all, will depend on, among other things, our financial performance, general economic factors, the condition of the credit and capital markets, and the continued listing of the ADSs on Nasdaq, some of which are beyond our control. There are currently no written agreements in place for such funding or issuance of securities, and there can be no assurance that management's plans will be effectively implemented. Accordingly, management's plans have not alleviated the substantial doubt about our ability to continue as a going concern.
Cash Flows
The following table sets forth a summary of our cash flows for the periods indicated.
|
(in thousands) |
Year ended December 31, |
|||||||||||||||
|
2025($) |
2025(¥) |
2024(¥) |
2023(¥) |
|||||||||||||
|
Net (loss) income |
$ |
(23,231 |
) |
¥ |
(3,642,581 |
) |
¥ |
138,191 |
¥ |
115,049 |
||||||
|
Net cash used in operating activities |
(7,366 |
) |
(1,155,007 |
) |
(1,331,681 |
) |
(631,737 |
) |
||||||||
|
Net cash (used in) provided by investing activities |
(143 |
) |
(22,456 |
) |
¥ |
361,393 |
¥ |
(328,576 |
) |
|||||||
|
Net cash (used in) provided by financing activities |
5,995 |
940,043 |
1,193,340 |
461,206 |
||||||||||||
|
Net (decrease) increase of cash and cash equivalents |
(1,514 |
) |
(237,420 |
) |
223,052 |
(499,107 |
) |
|||||||||
|
Cash and cash equivalents at beginning of period |
$ |
2,101 |
¥ |
329,399 |
¥ |
106,347 |
605,454 |
|||||||||
|
Cash and cash equivalents at end of period |
$ |
587 |
¥ |
91,979 |
¥ |
329,399 |
¥ |
106,347 |
||||||||
Operating Activities
Net cash used in operating activities was JPY1,155,007 thousand (US$7,366 thousand) for the year ended December 31, 2025, compared to JPY1,331,681 thousand for the year ended December 31, 2024. Net cash used in operating activities in 2025 principally reflected our net loss of JPY3,642,581 thousand, adjusted for non-cash items, including impairment losses on long-lived assets and goodwill of JPY2,550,953 thousand, depreciation and amortization of JPY532,657 thousand, deferred income taxes of JPY285,882 thousand and a change in provision for credit losses of JPY54,913 thousand, and for gain from sales of directly-owned salons of JPY1,072,740 thousand, the proceeds of which are presented within investing activities. Changes in operating assets and liabilities included an increase in accounts receivable-trade of JPY184,142 thousand, which was partially offset by an increase in accounts payable of JPY52,732 thousand, a decrease in accounts receivable-other of JPY266,713 thousand and an increase in other current liabilities of JPY29,843 thousand.
Investing Activities
Net cash used in investing activities was JPY22,456 thousand (US$143 thousand) for the year ended December 31, 2025, compared to net cash provided by investing activities of JPY361,393 thousand for the year ended December 31, 2024. Proceeds from the sale of salons were JPY540,140 thousand (US$3,445 thousand) for the year ended December 31, 2025, compared to JPY908,419 thousand for the year ended December 31, 2024.
Cash used for capital investments for the year ended December 31, 2025 was JPY562,596 thousand (US$3,588 thousand), consisting of JPY491,184 thousand for acquisitions of store operating rights in connection with reacquisitions of salons from investors, JPY61,111 thousand for acquisitions of intangible assets and JPY10,301 thousand for acquisitions of property and equipment. In addition, purchases of store operating rights of JPY285,693 thousand were included in accrued expenses as of December 31, 2025 and are therefore not reflected in net cash used in investing activities for the year.
Financing Activities
Net cash provided by financing activities was JPY940,043 thousand (US$5,995 thousand) for the year ended December 31, 2025, compared to JPY1,193,340 thousand for the year ended December 31, 2024. In 2025, cash flows from financing activities principally consisted of proceeds from short-term borrowings of JPY1,263,338 thousand and repayments of short-term borrowings of JPY789,778 thousand, proceeds from long-term borrowings of JPY180,321 thousand and repayments of long-term borrowings of JPY116,752 thousand, and proceeds of JPY400,000 thousand from the issuance of our Third Unsecured Convertible-Type Corporate Bonds with Share Options in December 2025. In 2024, cash flows from financing activities included proceeds of JPY608,101 thousand from the issuance of common stock in a public offering and JPY260,280 thousand from the issuance of preferred stock by MEDIROM MOTHER Labs Inc.
For a discussion of our cash flows for the fiscal year ended December 31, 2024 compared with the fiscal year ended December 31, 2023, see "Item 5. Operating and Financial Review and Prospects-B. Liquidity and Capital Resources" in our annual report on Form 20-F for the fiscal year ended December 31, 2024, filed with the SEC on April 29, 2025.
Business Loans
As of December 31, 2025, we had short-term borrowings of JPY765,227 thousand (US$4,880 thousand) and long-term borrowings (including the current portion) of JPY631,280 thousand (US$4,026 thousand).
Our short-term borrowings as of December 31, 2025 consisted of (i) an unsecured bank loan of JPY350,000 thousand, bearing interest at 1.875% per annum and maturing on March 31, 2026, which is guaranteed by MEDIROM MOTHER Labs Inc.; (ii) a bank loan with an outstanding balance of JPY191,671 thousand, bearing interest at a floating rate based on the lender's short-term prime rate, which was 1.875% per annum as of December 31, 2025, and maturing on March 31, 2026; (iii) a loan of JPY200,000 thousand from Kufu Company Holdings Inc. arising from the settlement of our First Unsecured Convertible-Type Corporate Bonds with Share Options on December 31, 2025, bearing interest at 10.0% per annum, maturing on December 30, 2026 and secured by a pledge of shares of MEDIROM MOTHER Labs Inc.; and (iv) a loan obtained by MEDIROM MOTHER Labs Inc. from a third party on June 23, 2025 with an outstanding balance of JPY23,556 thousand, bearing interest at 5.0% per annum, which originally matured on July 31, 2025 and was past due as of December 31, 2025. Interest at 14.6% per annum applied to this loan from December 2, 2025. This loan has subsequently been repaid in full. Our long-term borrowings mature at various dates through 2035 and had a weighted average interest rate of 2.96% per annum as of December 31, 2025. They include loans from Spirit Advisors to MEDIROM Wellness Co., which are denominated in U.S. dollars, bore interest at 8.0% per annum and had an outstanding balance of JPY156,530 thousand as of December 31, 2025, of which US$400 thousand was repayable in a lump sum on December 31, 2025 and US$600 thousand is repayable by December 31, 2027. On March 31, 2026, MEDIROM Wellness Co. and the lender entered into a loan amendment and restructuring agreement under which the loan that matured on December 31, 2025 (US$400 thousand) was restructured, together with accrued interest of US$15 thousand, into a loan bearing interest at 15.0% per annum from January 1, 2026, repayable in monthly installments from April 2026 with the final installment
due in September 2027. The remaining loan of US$600 thousand bears interest at 15.0% per annum and must be repaid by December 31, 2027. Kouji Eguchi, our Chief Executive Officer and a director, is a guarantor with respect to six loans (three bank loans of the Company and three disbursements under the loan agreement with Spirit Advisors), the outstanding amount of which was JPY339,330 thousand as of December 31, 2025. Kazuyoshi Takahashi, the representative director of ZACC, is a personal guarantor of two loans of ZACC, the outstanding amount of which was JPY25,245 thousand, and Yoshio Uekusa, the representative director of MEDIROM MOTHER Labs Inc., is a guarantor of one loan of MEDIROM MOTHER Labs Inc., the outstanding amount of which was JPY23,556 thousand. None of the borrowing agreements contain any material financial covenants, although certain of the government-sponsored loans set a limit on the total loan amount we may borrow from other government-sponsored lenders.
Additional information regarding our borrowings is included in Note 6 to our consolidated financial statements, and information regarding certain refinancing transactions since December 31, 2025 is included in "Item 4. Information on the Company-Subsequent Events" and Note 19 to our consolidated financial statements.
In addition, we have a fundamental funding and treasury policy of (i) maintaining a balanced ratio of debt to equity, and (ii) aligning our repayment of loans with our cash flow from business. Historically, our primary use of funds from our loans was capital expenditures on newly opened directly-owned salons, and we sought debt financing with longer than three-year terms and equal monthly repayment amounts of principal and interest in order to align our debt repayment schedule with our cash flows from our salon business operations. Since we suspended new salon openings, we have used borrowings primarily to refinance existing indebtedness, including our convertible bonds, and to fund working capital, and certain of these borrowings are short-term and repayable in a lump sum. In order to avoid interest rate risk during the terms of the loans, we generally enter into borrowings with fixed interest rates, and accordingly do not enter into hedging arrangements. One of our bank loans bears interest at a floating rate based on the lender's short-term prime rate. Since our primary business operations are in Japan, our borrowings from Japanese financial institutions are denominated in Japanese yen. We also have borrowings from parties that are not financial institutions, including Kufu Company Holdings Inc. and Triple One Investment Limited Partnership, and the loans from Spirit Advisors are denominated in U.S. dollars.
Convertible Bonds
As of December 31, 2025, we had JPY975,000 thousand (US$6,218 thousand) aggregate principal amount of convertible bonds outstanding, consisting of (i) JPY300,000 thousand of convertible bonds that we issued to Triple One Investment Limited Partnership, a Japanese limited liability investment partnership, in October 2024, (ii) JPY400,000 thousand of our Third Unsecured Convertible-Type Corporate Bonds with Share Options that we issued to 11 third-party investors on December 12, 2025, and (iii) JPY275,000 thousand of our Fourth Unsecured Convertible-Type Corporate Bonds with Share Options that we issued to Kufu Company Holdings Inc. on December 31, 2025.
The convertible bonds that we issued to Kufu Company Inc. in December 2022 in the aggregate principal amount of JPY500,000 thousand, the maturity date of which was amended to December 31, 2025 by an agreement dated November 1, 2024, were settled at maturity on December 31, 2025 as follows: (i) JPY275,000 thousand was refinanced through the issuance of our Fourth Unsecured Convertible-Type Corporate Bonds with Share Options to Kufu Company Holdings Inc.; (ii) JPY25,000 thousand was recorded in accounts payable at December 31, 2025 and paid after the year end; and (iii) JPY200,000 thousand was converted into a short-term loan from Kufu Company Holdings Inc., bearing interest at 10.0% per annum and secured by a pledge of shares of MEDIROM MOTHER Labs Inc. The exchange for the Fourth Unsecured Convertible-Type Corporate Bonds with Share Options was accounted for as an extinguishment of debt, and we recognized a loss on extinguishment of debt of JPY27,998 thousand for the year ended December 31, 2025.
The Third Unsecured Convertible-Type Corporate Bonds with Share Options are unsecured, accrue interest at a rate of 2.0% per annum and mature on June 30, 2026, subject to our option to extend the maturity date to December 25, 2026, unless earlier redeemed or converted. They are convertible into 1,166,175 common shares at a conversion price of JPY343 per share from December 12, 2025 to June 10, 2026 (or December 7, 2026 if the maturity date is extended). The Fourth Unsecured Convertible-Type Corporate Bonds with Share Options are unsecured, accrue interest at a rate of 5.0% per annum and mature on June 30, 2026, subject to our option to extend the maturity date to December 25, 2026, unless earlier redeemed or converted, and are convertible into 833,333 common shares at a conversion price of JPY330 per share from December 31, 2025 to June 29, 2026 (or December 24, 2026 if the maturity date is extended). For developments relating to these bonds after December 31, 2025, see "Item 4. Information on the Company-Subsequent Events."
In October 2024, we issued corporate convertible bonds in the aggregate principal amount of JPY300,000 thousand (US$1,913 thousand) to Triple One Investment Limited Partnership, a Japanese limited liability investment partnership. The bonds are unsecured, accrue interest at a rate of 2.0% per annum, payable on June 30, 2025 and semi-annually thereafter, and will mature on October 29, 2027. At any time between October 25, 2024 and October 29, 2027, Triple One may convert each bond, which are issued in denominations of JPY100,000 thousand and may be converted in whole but not in part, into our common shares at a conversion price of JPY957 per share by exercising stock options that were issued to Triple One in connection with the bonds. In addition, there are certain conditions under the bond indenture, such as our failure to timely pay interest and remedy the
nonpayment within a cure period, upon the occurrence of which Triple One is entitled to demand immediate repayment of the bonds. On August 25, 2026, we redeemed all of these bonds prior to their maturity and concurrently borrowed JPY300,000 thousand from Triple One, with the redemption price and the loan being settled by set-off. The loan originally bore interest at 5.0% per annum and had a maturity date of September 15, 2026, and was not repaid on that date. On November 11, 2026, the lender and we entered into an agreement amending the loan, under which the maturity of the principal was extended to December 30, 2026, with JPY5,000 thousand of the principal is repayable on November 30, 2026 and the balance on the maturity date. Interest accruing on and after November 1, 2026 accrues at 14.6% per annum and is payable monthly at each month-end. It is secured by a pledge of all of the shares of MEDIROM Rehab Solutions Inc. that we hold and by a pledge over the operating rights of ten salons that we operated when the security was granted. Two of those salons have since been transferred to third-party investors, and we are in discussions with the lender regarding the terms of the security agreement, which permits us to propose substituting the operating rights of other salons of equivalent value.
Corporate Bonds
On July 22, 2024, we issued corporate bonds in aggregate principal amount of JPY70,000 thousand to Tan Lee, an individual. On September 17, 2024, we repaid JPY40,000 thousand of such bonds. As of December 31, 2025, the outstanding balance of such corporate bonds was JPY30,000 thousand (US$191 thousand). The bonds bear interest at 6.0% per annum (2.0% per annum at issuance) and were scheduled to mature on April 30, 2026. On April 30, 2026, we and the holder agreed to extend the maturity date to December 31, 2026, at which date the amount payable will be JPY34,332 thousand (US$219 thousand), consisting of principal of JPY30,000 thousand and accrued interest of JPY4,332 thousand. The bonds have been neither repaid nor refinanced as of the date of this annual report.
Cash Commitments from Contractual and Other Obligations
Payments of contractual obligations and commitments will require considerable resources. In our ordinary course of business, we routinely enter into commercial commitments and financial obligations for various aspects of our operations. The following tables set forth the amount of our contractual obligations as of December 31, 2025
|
(in thousands JPY) |
Payments due by period: |
|||||||||||||||
|
Total |
Less than |
1-3 years |
More than |
|||||||||||||
|
Long-term borrowings, corporate bonds and |
1,636,560 |
836,321 |
612,085 |
188,154 |
||||||||||||
|
Short-term borrowings |
765,227 |
765,227 |
- |
- |
||||||||||||
|
Operating lease obligations |
1,807,946 |
778,051 |
791,638 |
238,257 |
||||||||||||
|
Other obligations |
7,583 |
1,795 |
5,788 |
- |
||||||||||||
|
Total |
4,217,316 |
2,381,394 |
1,409,511 |
426,411 |
||||||||||||
Research and Development, Patents and Licenses, etc.
Our research and development activities have been focusing on development of Lav® which is our on-demand health monitoring smartphone application, embedded software or smartphone application for our MOTHER Bracelet®, and development of REMONY®, a centralized monitoring system through which health data generated from MOTHER Bracelet® worn by end users can be collected and monitored by the staff of hospitals, nursing homes, and any other business clients. Costs and expenses in connection with these development activities are capitalized as software assets, which are amortized over three to five years.
Trend Information
For a discussion of material trends, uncertainties and other events that are reasonably likely to have a material impact on the Company, see "Operating Results" in Item 5.A. and "Liquidity and Capital Resources" in Item 5.B. above.
Our consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make a number of estimates and assumptions that affect the reported amounts and disclosures in the consolidated financial statements. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. We base our accounting estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. However, actual results may differ from those estimates. Our critical accounting policies are those that materially affect our consolidated financial statements and are subject to complex judgment by our management.
Revenue Recognition
Revenues are recognized when control of the promised goods or services are transferred to the customers, in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services.
The Company determines revenue recognition through the following steps:
Step 1: identification of the contract with a customer;
Step 2: identification of the performance obligations in the contract;
Step 3: determination of the transaction price;
Step 4: allocation of the transaction price to the performance obligations in the contract;
Step 5: recognition of revenue when, or as, the Company satisfies a performance obligation.
Revenue from Directly-Operated Salons
Revenues from directly-operated salons (including sales in the Luxury Beauty segment) are recognized when services are provided at the salons. The promised services for directly-operated salons are the services ordered by the end customer from the service menu. The services are provided in one appointment. Therefore, there is only one performance obligation. As the customer simultaneously receives and consumes the benefits of the relaxation services, the revenue is recognized over time using the delivery output method.
Revenue from prepaid cards is recognized when the services are transferred. When value is added to a prepaid card, the Company records a contract liability for its performance obligation to stand ready to transfer services in the future (or transfer funds to franchisee who provides service). When the services or funds are transferred, it derecognizes the contract liability and correspondingly recognizes revenue net of any funds transferred to franchisees. The Company expects to be entitled to a certain amount of breakage and recognizes revenue from breakage proportionately to the redemptions exercised by the customer.
The Company also sells salons to third-party investors. Developing and selling salons is a recurring part of the business model of the Relaxation Salon segment (the Company sold 43, 60 and 38 salons in 2025, 2024 and 2023, respectively, representing 18%, 28% and 15% of total revenues); accordingly, the sale of salons is considered part of the Company's ongoing major or central operations and thus ordinary activities for the Company, and the third-party investors are considered as "customers".
Therefore, the Company applies ASC 606 to these contracts. The store operating rights transfer agreement and the service agreement with an investor are negotiated as a package and entered into at the same time, and are accounted for as a single contract with two performance obligations: (i) transfer of the salon assets and business rights and (ii) outsourced salon operation services. The transfer price, which is determined based on the estimated profit of the salon and the yield expected by the investor, is allocated to (i), and the cost reimbursements and success fee under the service agreement are allocated to (ii), as these contractual prices represent their standalone selling prices. The revenue for the transfer of salon assets and business rights is recognized at a point in time when control of the salon transfers to the investor at the point of legal transfer. In connection with the sale of salons, the disposition of related salon assets, such as store equipment, leasehold improvements, store operating rights and goodwill, if applicable, is recorded in cost of revenue.
The Company may purchase sold salons back from third-party investors based on those investors' demands and the Company's business strategy. These repurchases are not subject to any contractual or implied repurchase obligations and, as such, do not preclude revenue recognition under ASC 606. There is no substantive repurchase right or obligation associated with these transactions, based on the absence of contractual guarantees or economic compulsion. If the Company enters into a salon purchase and sales agreement with the same investor on the same date or near the same date, the Company accounts for the agreements as a combined arrangement, under which the proceeds from the sale of the salon and the payment for the purchase of the salon are offset against each other, and the Company recognizes the noncash consideration and the difference between the carrying value of the sold salon and the transaction amount as other income or loss, which is included in gain from sales of salons in the consolidated statements of operations. Where the Company purchases a salon from one third-party investor and sells it to a different third-party investor on the same date, the Company's performance obligation is to arrange for the provision of the salon by another party and the seller effectively controls the salon before it is transferred to the new investor; accordingly, the Company is considered to be an agent in these transactions and records the related revenue on a net basis. There is no significant financing component.
The Company classifies both cash inflows from salon sales and cash outflows related to salon repurchases as investing activities in the consolidated statements of cash flows in accordance with ASC 230-10-45-12(c), as they represent disposals and acquisitions of productive assets.
The buyers of salons are entitled to enter into Service Agreements with the Company to manage the operations of the salons, for which the Company charges a fee. Revenue from the Service Agreement is recognized over the term of the agreement as services are provided. The customer benefits from the integrated service over the contract term and each time increment is substantially the same. Therefore, the outsourced salon operations are considered a "series" of distinct services and are treated as a single performance obligation. The term of the Service Agreement is typically five years. Under the Service Agreement, the Company is reimbursed for the costs of operating the salon, including leases. Although the Company invoices the investors for such costs annually, the Company's right to consideration arises monthly as the costs are incurred and corresponds directly with the value of the services performed to date; accordingly, the Company recognizes revenue from the reimbursement of costs using the as-invoiced (right to invoice) practical expedient. The Company also receives, as a success fee, a portion of the salon's profit in excess of the investor's target yield. The success fee is consideration for the operation services, as the investor retains the target return and bears any operating losses of the salon, and is considered variable consideration. This success fee is constrained until it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur.
Franchise Revenue
Franchise revenue is comprised of (i) franchise fees, (ii) royalty income, (iii) staffing service revenue, (iv) sublease revenue, and (v) other franchise revenues. The Company and the franchisee enter into a franchise agreement which sets forth the standard terms and conditions of operating the franchised salon, as well as the fees and royalties over the term of the agreement. In most cases, an outsourcing agreement is also entered into in conjunction with the franchise agreement that specifies the terms of the sublease arrangement with the franchisee. Upon the franchisee's request, the Company's therapists are dispatched to franchise locations and franchisees must pay dispatch fees in accordance with the dispatched employees' position.
The Company receives the entire non-refundable initial franchise fees from the franchisee based on franchise agreement. The franchise agreement typically has an initial term of five years. The services for operating the franchised salon provided by the Company under franchise contract are not separately identifiable within the contract, and are interrelated with the franchise right granted in the franchise agreement. As such the services are considered to represent a single performance obligation. The franchise agreement could be renewed prior to expiration by mutual consent and renewal franchise fees are paid by franchisee upon renewal of agreement. Initial franchise fees and expected renewal franchise fees are recognized as revenue ratably using the time-based input method over the expected average contract life (7 years), instead of the contract term, as there is a material right related to renewals.
The Company collects royalties, an amount calculated by multiplying a certain percentage to gross sales, on a monthly basis. The royalties are subject to the sales- and usage-based royalties constraint and are recognized as revenues based on the monthly royalty earned where such amount is determined on the basis of gross sales made from each salon.
The Company also generates revenue from providing its therapists to franchisees, which are recognized as revenues based on the total number of working hours of the agency worker during the dispatched period. The Company has elected the 'as-invoiced' practical expedient for its staffing services where the fixed rate per hour is invoiced to the customer.
The Company leases the premises in which the majority of its franchisees operate, where the Company retains the head lease primary obligation, and has entered into corresponding sublease arrangements with franchisees. Revenues from sublease transactions with franchisees are recognized on a straight-line basis over the respective operating lease terms, or at the time of the underlying sales for variable lease payments, in accordance with Accounting Standards Codification ("ASC") 842 Leases ("ASC 842").
Other franchise revenues include other services provided to franchisees separately from the franchise agreements and include advertising, training, studio construction and hiring support. These services are primarily recognized as revenues when services are provided. The Company has elected the 'as-invoiced' practical expedient for its studio construction services where the consideration is invoiced to the customer.
Other Revenues
Other revenues are primarily from the Digital Preventive Healthcare segment, which includes revenues from serving implementation of health and wellness programs (Specific Health Guidance Program), as well as wearable device service (MOTHER Bracelet®), and are recognized when services are provided or the ownership of products are transferred. The Company offers standard assurance-type warranties for its MOTHER Bracelet® which are not accounted for as a separate performance obligation and do not contain acceptance clauses.
See Note 13 to the consolidated financial statements included elsewhere in this annual report for further disclosures required under ASC 606.
Revenue is recognized net of consumption tax collected from customers and subsequently remitted to governmental authorities.
Leases
The Company considers whether a contract is a lease or if it contains a lease element when a contract is executed. If a contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration, such contract is determined to contain a lease element. When the contract contains a lease element, a lease is either classified as operating lease or finance lease when the Company is a lessee, and a sales-type lease or direct financing lease when the Company is a lessor.
The Company, as a lessee, applies the right-of-use model to account for lease transactions. Under the right-of-use model, right-of-use asset and lease liability are recognized at commencement date. The Company measures its lease liability at present value of future lease payments over the remaining term. The Company uses its incremental borrowing rate for the discount rate to calculate the present value of the payments since it is difficult and not practical to determine the interest rate implicit in the lease. The Company's incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Right-of-use asset is initially measured as the initial amount of the lease liability, plus any lease payments made to the lessor before the lease commencement date, plus any initial direct costs incurred, minus any lease incentives received. When the Company determines a lease term, if a lease contract contains an option to extend its lease term, the Company is reasonably certain to exercise such option. This is mainly due to the severe economic loss the Company may face for not exercising the right of extension, such as recognizing impairment loss of attached facilities and loss resulting from failure to receive the franchise fee originally obtainable. Therefore, the lease term includes the extended term if the option to extend is exercised. Initial lease terms are generally between three and 10 years.
For operating leases, the Company recognizes the minimum lease payments where it is the lessee and the minimum lease income where it is the lessor on a straight-line basis over the lease term, and reflects them as rental expenses and rental revenues, respectively, in the consolidated statements of operations. The Company elected to separate lease and non-lease components and not to recognize leases with an initial term of 12 months or less.
Operating rental expense includes amortization of right-of-use assets and interests on lease liability. Variable lease expenses are primarily linked to sales and are excluded from the measurement of lease liability.
Rental expenses are recorded in the consolidated statements of (loss) income based on the nature of the underlying lease. Rental expense related to leases for directly-operated salons and for leased properties that are subsequently subleased to franchisees are recorded to "Cost of revenues," and rental expense related to leases for corporate offices is recorded to "selling, general and administrative expenses."
Rental income for operating leases on properties subleased to franchisees is recorded to "Franchise revenue". Terms and conditions of the sublease agreements are arranged to pass through lease obligations under head leases to the franchisees. Sublease income is presented on a gross basis on the accompanying consolidated statements of income, as the Company remains the primary obligor.
For newly executed contracts, renewal and revision related to leases, estimates and certain assumptions are used to determine asset value, useful lives, discount rate, lease term, etc. and these have effects on (1) classification of lease, (2) measurement of rental payments and (3) measurement of lease asset. These results may differ if varying estimates and assumptions are used.
Impairment of Long-lived Assets, Excluding Goodwill
The Company assesses impairment of long-lived assets at the individual salon level, as this is the lowest level for which identifiable cash flows are largely independent of other groups of assets and liabilities. Long-lived assets include property and equipment, right-of-use lease assets, internal use software, and definite-lived intangible assets. The Company reviews the carrying
value of long-lived assets for impairment whenever events or circumstances occur that indicate that the carrying value of the assets may not be recoverable.
The assets are considered to be impaired when the estimated undiscounted cash flows expected to result from the use of the assets and their eventual disposition are less than their carrying values. The undiscounted cash flows are estimated over the remaining useful life of the primary asset of the asset group or, for salon asset groups with store operating rights, over 10 years based on the Company's lease renewal history. The impairment loss is measured as the amount by which the carrying value of the asset or asset group exceeds its fair value. Fair value is determined based on Level 3 inputs. The fair value of salon asset groups with store operating rights reacquired from investors is estimated using a market approach based on EBITDA multiples observed in the Company's salon transactions with investors, and the fair value of asset groups with negative expected cash flows is estimated to be nil.
We recognized an impairment loss on long-lived assets of JPY2,204,327 thousand (US$14,058 thousand) in 2025 and JPY22,872 thousand (US$146 thousand) in 2024, while we recognized no impairment loss of long-lived assets in 2023. In addition, we recognized goodwill impairment losses of JPY346,626 thousand in 2025.
Income Taxes
Deferred income taxes reflect the impact of temporary differences between assets and liabilities recognized for financial reporting purposes and such amounts recognized for tax purposes and tax loss carryforwards. These deferred taxes are measured using the currently enacted tax rates in effect for the year in which the temporary differences or tax loss carryforwards and tax credits are expected to reverse.
Valuation allowances are provided against deferred tax assets when it is more likely than not that a tax benefit will not be realized. The Company considers all available evidence (both positive and negative) when determining whether a valuation allowance is required, with emphasis on its past operating results, the existence of cumulative losses in the most recent years and its forecast of near-term taxable income. The Company recognizes the financial statement effect of uncertain tax positions when it is more likely than not, based on the technical merits, that the tax positions will be sustained upon examination by the tax authorities. Benefits from tax positions that meet the more-likely-than-not recognition threshold are measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon settlement. The Company classifies interest and penalties related to income taxes, including those related to unrecognized tax benefits, if any, within selling, general and administrative expenses in the consolidated statements of operations.
Acquisitions
The Company evaluates acquisitions of assets and other similar transactions to assess whether or not the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the screen is met, the transaction is accounted for as an asset acquisition. If the screen is not met, further determination is required as to whether or not we have acquired inputs and processes that have the ability to create outputs which would meet the definition of a business. Significant judgment is required in the application of the screen test to determine whether an acquisition is a business combination or an acquisition of assets.
If an acquisition is determined to be a business combination, the assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the estimated fair values of the identifiable net assets acquired is recorded as goodwill.
If an acquisition is determined to be an asset acquisition, the cost of the asset acquisition, including transaction costs, are allocated to identifiable assets acquired and liabilities assumed based on a relative fair value basis. If the cost of the asset acquisition is less than the fair value of the net assets acquired, no gain is recognized in earnings. The excess fair value of the acquired net assets acquired over the consideration transferred is allocated on a relative fair value basis to the identifiable net assets (excluding non-qualifying assets).
Determining estimated fair value requires a significant amount of judgment and estimates. If assumptions change or errors are determined in our calculations, the fair value could materially change resulting in a change in goodwill or identifiable net assets acquired.
In 2024, we acquired the rehabilitation business of Y's Inc., with MEDIROM Rehab Solutions Inc., our 100% subsidiary, as the acquiring entity. For more details of the accounting treatments of the acquisition, see Note 2 to our consolidated financial statements.
Recently Issued Accounting Pronouncements Adopted
Segments
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new standard requires enhanced disclosures about segment information and significant segment expenses. It does not change how a public entity identifies its operating segments. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The new standard has been applied retrospectively to all periods presented in Note 11.
Income Taxes
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information about the effective tax rate reconciliation, using both percentages and reporting currency amounts for specific categories, and income taxes paid by jurisdiction. The Company adopted ASU 2023-09 for the year ended December 31, 2025 on a prospective basis. See Note 12 to our consolidated financial statements included elsewhere in this annual report. The adoption affected disclosures only.
Recently Issued Accounting Pronouncements Not Yet Adopted
Disclosure Improvements
In October 2023, the FASB issued ASU No. 2023-06, Disclosure Improvements-Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative. This new standard modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC's regulations. ASU 2023-06 will become effective for each amendment on the effective date of the SEC's corresponding disclosure rule changes. The Company is currently evaluating the impact on its consolidated financial statements.
Comprehensive Income - Expense Disaggregation
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, to disclose additional information about specific expense categories. In January 2025, the FASB issued ASU 2025-01 Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40), which clarified the effective date for ASU 2024-03. These amendments are intended to provide more information about types of expenses in commonly presented expense captions. The amendments in this update are effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impact on the consolidated financial statements and related disclosures.
Debt-Debt with Conversion and Other Options
In November 2024, the FASB issued ASU 2024-04, Debt-Debt with Conversion and Other Options, which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06. The Company will adopt ASU 2024-04 on January 1, 2026 and does not expect the adoption to have a material impact on its consolidated financial statements.
Business Combinations and Consolidation
In May 2025, the FASB issued ASU 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity, which requires an entity to consider the general factors in ASC 805 when identifying the accounting acquirer in an acquisition of a VIE that meets the definition of a business. ASU 2025-03 is effective for fiscal years beginning after December 15, 2026, including interim periods within those fiscal years, and is applied prospectively. The Company is currently evaluating the impact on its consolidated financial statements.
Credit Losses
In July 2025, the FASB issued ASU 2025-05, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient to assume that current conditions as of the balance sheet date do not change for the remaining life of current accounts receivable and current contract assets. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, including interim periods within those annual reporting periods, and is applied prospectively. The Company is currently evaluating the impact on its consolidated financial statements.
Internal-Use Software
In September 2025, the FASB issued ASU 2025-06, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which removes all references to software development project stages and requires capitalization of software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027, including interim periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements.
Government Grants
The FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which establishes guidance on the recognition, measurement and presentation of government grants received by business entities. ASU 2025-10 is effective for public business entities for annual reporting periods beginning after December 15, 2028, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-10 on its consolidated financial statements.